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are predicted to be the most affected by AMR 5 . We implemented WGS within the 8 established Antimicrobial Resistance Surveillance Program (ARSP) of the Philippines via 9 ongoing technology transfer, capacity building in and binational collaboration. In parallel, 10
we conducted an initial large-scale retrospective sequencing survey to characterize 11 bacterial populations and dissect resistance phenotypes of key bug-drug combinations, 12 which is the focus of this article. Starting in 2010, the ARSP phenotypic data indicated 13 increasing carbapenem resistance rates for Pseudomonas aeruginosa, Acinetobacter 14 baumannii, Klebsiella pneumoniae and Escherichia coli. We first identified that this 15 coincided with a marked expansion of specific resistance phenotypes. By then linking the 16 resistance phenotypes to genomic data, we revealed the diversity of genetic lineages 17 (strains), AMR mechanisms, and AMR vehicles underlying this expansion. We discovered 18 a previously unreported plasmid-driven hospital outbreak of carbapenem-resistant K. 19 pneumoniae, uncovered the interplay of carbapenem resistance genes and plasmids in 20 the geographic circulation of epidemic K. pneumoniae ST147, and found that 21 carbapenem-resistant E. coli ST410 consisted of diverse lineages of global circulation that 22 carried both international and local plasmids, resulting in a combination of carbapenemase 23 genes variants previously unreported for this organism. Thus, the WGS data provided an 24 enhanced understanding of the interplay between strains, genes and vehicles driving the 25 Introduction 1 2 Antimicrobial resistance (AMR) is an increasingly serious threat to global public health and 3 the economy that requires concerted action across countries, government sectors and 4 non-government organizations 1 . Without AMR containment, an adverse impact on 5 medical costs, global gross domestic product (GDP), livestock production and international 6 trade is expected by 2050, and the sustainable development goals for 2030 are less likely 7
to be attained 5 . The Global Action Plan developed by the World Health Organization 8 (WHO) to tackle AMR highlights the need to strengthen our understanding of how 9 resistance develops and spreads, and the underlying resistance mechanisms 2 . One of the 10 pillars of this objective is the national surveillance system for antimicrobial resistance. 11
An advanced example of a national surveillance system is the Antimicrobial Resistance 12
Surveillance Program (ARSP), the national laboratory-based surveillance of the Philippine 13 Department of Health (DOH). The ARSP began in 1988 with ten tertiary hospitals (sentinel 14 sites) and the Antimicrobial Resistance Surveillance Reference Laboratory (ARSRL) in 15
Metro Manila and has since expanded to 25 sentinel sites and two gonorrhoea 16 surveillance sites in all 17 regions of the country (Supplementary Figure S1 ). Surveillance 17 encompasses common pathogens of public health importance in the Philippines, where 18 infectious diseases represented nine out of the ten leading causes of morbidity 6 , and four 19 out of the ten leading causes of infant mortality 7 in 2013-2014. Results of culture-based 20 identification and antimicrobial susceptibility are stored centrally at the ARSRL within the 21 clinical microbiology management software WHONET ( Figure 1A, 8 ). A report summarizing 22 the resistance trends is published annually and disseminated to local, national and 23 international surveillance stakeholders 9 . For policy change, surveillance data generated 24 by ARSP is used by the DOH to develop clinical practice guidelines and determine the 25 panel of antibiotics to be included in the national formulary. Furthermore, ARSP has been 1 contributing data to international AMR surveillance programs since the 1980s, including 2 the Global Antimicrobial Surveillance System (GLASS 10 ) since 2015. Importantly, the 3 ARSP data has informed the Philippine National Action Plan to combat AMR, one of the 4 key requirements for alignment with the WHO global action plan. 5
The Philippines has seen a steady increase in resistance rates for several key pathogen-6 antibiotic combinations in the last ten years, including carbapenem-resistant organisms 7
( Figure 1B) . The genetic mechanisms underlying carbapenem resistance, one of the 8 biggest therapeutic challenges in the treatment of antimicrobial resistant infections, include 9 increased upregulation of efflux pumps, decreased uptake by altered expression/loss of 10 porin function, and acquisition of hydrolytic enzymes -carbapenemases 11 . Whole-genome 11 sequencing (WGS) of bacterial pathogens can identify distinct clonal lineages (strains) on 12 phylogenetic trees, known AMR mechanisms (genes or mutations) and the vehicles for the 13 acquired AMR genes (mobile genetic elements, MGEs) which, in turn, enables enhanced 14 detection and characterization of high-risk clones ( Figure 1A ). WGS is routinely used for 15 infectious disease epidemiology in several high-income countries around the world, where 16 it has improved outbreak investigations and epidemiological surveillance 12, 13 and 17 enhanced our knowledge of the spread of antimicrobial-resistant strains and their 18 resistance mechanisms 3, 4 . Elucidation of resistance mechanisms and their context can be 19 critical for effective infection control. For example, upregulation of efflux pumps and loss of 20 porin function by mutation are vertically transmitted, while acquired carbapenemases 21 carried in transmissible plasmids or integrative conjugative elements have the potential for 22 horizontal dissemination between strains and species, thus necessitating enhanced 23 infection control measures 14 . Moreover, diverse carbapenemase classes, variants, 24
flanking MGEs, and associated plasmid incompatibility groups have been described, 25 requiring multiple biochemical and molecular tests for identification. For example, the class 1 B New Delhi metallo-beta-lactamase (NDM) is found worldwide, represented by over ten 2 different variants that are usually upstream of intact or truncated ISAba125 elements, 3 within plasmid backbones of different incompatibility groups, across multiple lineages of E. 4 coli -as well as of other carbapenem-resistant organisms 15, 16 . WGS can determine the 5 interplay between these different components, i.e. the gene, the vehicle, and the strain, 6 thus maximizing the epidemiological benefit derived from its cost. 7 Implementation of WGS within existing national surveillance systems in LMICs has the 8 potential to enhance local prevention and control of resistant infections in a sustainable 9 and equitable manner. Integration of WGS into routine surveillance of AMR can be 10 facilitated by international collaboration focused on transfer of expertise and ownership. 11
Our collaboration (See and Sequence, Figure 1A ) aimed to implement WGS within the 12 ARSP via a multi-faceted approach that included a large initial retrospective sequencing 13 survey, technology transfer, utilization of user-friendly web applications, and capacity 14 building in laboratory and bioinformatic procedures for local prospective sequencing. We 15 linked what has traditionally been used as the operational unit of laboratory surveillance, 16 the resistance profile, with the operational unit of genomic epidemiology now provided by 17 WGS, genetic relatedness. Here we provide exemplars from the retrospective sequencing 18 survey that highlight how the granular view of strain-gene-vehicle in carbapenem-resistant 19 populations at the local, national and global operational scales can be leveraged for 20 surveillance of AMR and public health. 21
Results 1
The Philippine Antimicrobial Resistance Surveillance Program (ARSP) collects bacterial 2 isolates and stores the associated clinical and epidemiological data in the WHONET 3 software 8 . Antibiograms are stored as resistance profiles, which represent the diversity of 4 AMR phenotypes in the country. In parallel to local WGS capacity building, we conducted 5 a large retrospective sequencing survey of eight bacterial pathogens to provide genomic 6 context for local prospective surveillance. Here, we focus on the carbapenem-resistant 7 organisms, which have been classified as of critical priority for the development of new 8 antibiotics by the World Health Organization (WHO). 9
10
Operational unit of laboratory surveillance -Routine laboratory surveillance highlights the 11 increasing burden of specific resistance phenotypes 12
Carbapenem-resistant P. aeruginosa, A. baumannii, K. pneumoniae and E. coli were all 13 first isolated by ARSP between 1992 and 1994. Since the year 2000 resistance rates to 14 imipenem and meropenem have remained below 30% for all organisms except for A. 15
baumannii, which has seen a steady rise in resistance rates between 2009 and 2017, 16 reaching 56% (Figure 2A ). This coincides with the expansion of two resistance profiles 17 (RP), first a striking expansion of true-XDR and possible-PDR RP-1, and later of true-XDR 18 RP-2 (full profiles can be found in Figure 2B ). Yearly resistance rates for P. aeruginosa 19 have oscillated between 10-25% since the year 2000, and have doubled between 2010 20 and 2013 ( Figure 2A ). Two resistance profiles have seen the largest combined expansion 21 between 2011 and 2013, possible-PDR RP-3, and true-XDR RP-4 ( Figure 2B ). The yearly 22 resistance rates to imipenem for Enterobacteriaceae were approximately 3% in 2011 but 23 have since steadily increased to 5% for E. coli and 11% for K. pneumoniae, respectively 24 ( Figure 2A ). This coincides with the expansion of three possible-XDR resistance profiles, 1 RP-5, RP-6, and RP-7 ( Figure 2B ). The observed expansion of specific resistance profiles 2 could be driven by the rapid dissemination of a discrete genetic lineage (strain) carrying 3 AMR determinants or, alternatively, of transmissible MGEs, which shuttle resistance 4 determinants across different genetic lineages. 5
6
Operational unit of genomic surveillance -WGS reveals the genetic diversity and AMR 7 mechanisms underpinning carbapenem resistance phenotypes 8
The sequences of 805 genomes linked to WHONET data were obtained from isolates 9
belonging to the four bacterial pathogens in the WHO critical list (Table 1) , which were 10 collected in 2013 and 2014 by between thirteen to eighteen ARSP sites. The isolates 11 sequenced were non-susceptible to carbapenems and/or to extended-spectrum 12 cephalosporins (Table 1) , with the exception of P. aeruginosa, for which susceptible 13
isolates were available and also sequenced. 14 The distribution of the carbapenem resistance profiles highlighted in Figure 2 was not 15 concordant with the major clades observed on the phylogenetic trees ( Figure 3 ). Instead, 16 the same resistance profile was usually observed in multiple genetic lineages across the 17
tree. Yet, the distribution of the multi-locus sequence types (STs), a molecular genotyping 18 method inferred from the sequences of seven house-keeping genes, was largely 19 concordant with the major clades observed on the trees inferred from whole-genome 20 single-nucleotide polymorphisms (SNPs) (Figure 3 ), confirming that the homoplasic 21 distribution of resistance profiles was not an artefact of the tree topology. The distribution 22 of the same carbapenem resistance profiles across multiple genetic lineages was 23 observed both at the national and local levels (Supplementary Figure S2 ), as the number 24 of ST assignments increased with the number of isolates representing a resistance profile. 1 Thus, the genomic data suggests that expansion of specific carbapenem resistance 2 profiles in the Philippines is driven by the horizontal dissemination of resistance 3 determinants across diverse genetic backgrounds, rather than by the sole expansion of 4 single resistant genetic clones, and that resistance to multiple antibiotics is acquired en 5 bloc via MGEs, as previously observed for carbapenem-resistant organisms 16 . 6
Carbapenemases are a diverse collection of hydrolytic enzymes 16 , and we identified 7 representatives of class A, B and C carbapenemases in the Philippines (Supplementary 8 Figure S3 ). Class B NDM-1 and Verona integron-borne metallo-beta-lactamase VIM-2 9
were the most prevalent and geographically disseminated in the Enterobacteriaceae and 10 P. aeruginosa, respectively, while the same was true for class D OXA-23 in A. baumannii. 11
Importantly, different carbapenemase genes/variants (or combinations thereof) were found 12 underlying the same resistance profiles in all four organisms ( Figure 3 ). Figure S4A) . 20
Phylogenetic analysis of these 15 genomes in the wider context of ST340 indicated three 21 main lineages, with the 15 possible-XDR isolates from MMH forming a tight cluster (clade 22 III, Figure 4A ). The shorter branch lengths in the imipenem-resistant clade III (6.5±3.7 23 pairwise SNP differences) compared to the imipenem-susceptible clade II (26.8 ±6.9 24 pairwise SNP differences, Mann-Whitney U test z-score -6.265, p-value= 3.71x10 -10 , 1
Supplementary Figure S4B ), and the isolation dates spanning twelve months, suggest a 2 rapid expansion of this clone, which coincides with the acquisition of the blaNDM-1 gene 3 ( Figure 4A ). 4
Epidemiological data showed that the samples were mostly hospital-acquired (N=14), and 5 from neonates (N=12) ( Figure 4A ). These observations triggered a retrospective 6 epidemiological investigation that revealed that 10 of the isolates originated from patients 7 of the neonatal intensive care unit (NICU), all of which had umbilical catheters and were on 8 mechanical ventilators. The remaining cases were either from paediatric wards (N=4) or 9 the male ward (N=1), suggesting wider dissemination of this high-risk clone within the 10 hospital environment. 11
The genetic diversity underlying the 33 possible-XDR isolates from MMH (12 STs) 12 prompted us to investigate the hypothesis of dissemination of carbapenem resistance in 13 the hospital by a plasmid carrying blaNDM-1. We identified a 101,540 bp IncFII plasmid with 14 blaNDM-1, rmtC, and sul1 (p13ARS_MMH0112-3, Table 2 and Supplementary Results and 15 Figure S5 ) in a representative isolate from ST340 clade III. In addition, we found the entire 16 p13ARS_MMH0112-3 plasmid sequence (i.e. ³95% of the length) represented in 27 17 genomes from 9 different sequence types, including 20 samples from 6 different sequence 18 types isolated from patients under 1 year old ( Figure 4B ). 19
Altogether, our findings suggest that the burden of carbapenem-resistant K. pneumoniae 20 infections in hospital MMH was largely linked to plasmid p13ARS_MMH0112-3 with 21 blaNDM-1, circulating within diverse genetic lineages, and leading to outbreaks in high-risk 22 patient populations. Hospital authorities were informed of these findings, and measures for 23 infection control were implemented, including designating a separate multi-drug resistance 24 organism (MDRO) room for cohorting, active surveillance upon identification of any new 25 carbapenem-resistant K. pneumoniae from the NICU, and referral of any new 1 carbapenem-resistant K. pneumoniae from the NICU to ARSRL for sequencing. 2 3 Scale of surveillance -National: WGS reveals the interplay of carbapenem resistance 4 genes and plasmids in the regional circulation of a successful K. pneumoniae lineage 5
The possible-XDR resistance phenotype "AMP FOX CAZ CRO FEP IPM AMC TZP CIP 6
SXT" (RP-5) was represented by 76 K. pneumoniae isolates from 14 different STs. 7
Seventy-one percent (N=54) belonged to ST147, an international epidemic clone that was 8 found in 11 sentinel sites in all 3 island groups in the Philippines. The phylogeny of the 9 ST147 genomes showed that carbapenem non-susceptible isolates (78·8%, N=63) were 10 found in clades arising from 3 out of 4 deep branches of the tree ( Figure 5A ), which 11 represent separate groups of the global population (Supplementary Figure S6A) . Plasmid sequences obtained from isolates representing different carbapenem-resistant 16 clusters in clades III and IV showed that the NDM genes were carried within different 17 variants of the insertion sequence ISAba125 on different plasmid backbones, two of which 18 showed high sequence similarity to international plasmids (Table 3 and characterized by plasmid p14ARS_MMH0055-5 carrying blaNDM-7, while another cluster of 23 genomes from VSM and NMC were distinguished by plasmid p13ARS_VSM0593-1 with 24 blaNDM-1. Plasmids p13ARS_GMH0099 and p14ARS_VSM0843-1, both carrying blaNDM-1 1 were found in different subclades of clade IV, one of local circulation in hospital VSM, and 2 another one showing regional expansion across 5 sentinel sites ( Figure 5A ). Taken 3 together, the phylogeographic signal (strains) in combination with the distribution of blaNDM 4 variants (mechanism) and plasmids (vehicle), revealed local and regional patterns of 5 circulation of carbapenem non-susceptible ST147 within the Philippines, which could not 6 be identified based solely on the resistance profiles or MLST information. Furthermore, 7 comparison with global ST147 genomes indicated that clade IV may be unique to the 8 Figure S6A ). Figure S8 ). The phylogenetic tree of 24 18 ST410 genomes showed that isolates with the possible-XDR profiles clustered within one 19 clade ( Figure 6A ), which can be further delineated by the distribution of carbapenemase 20 genes and variants into three different clones carrying blaNDM-4 (N=1), blaNDM-1 (N=8), or 21 both blaNDM-1 and blaOXA-181 (N=5). The phylogenetic analysis with global E. coli ST410 22
Philippines (Supplementary Results and
genomes confirmed that these are independent clones, as they were found interspersed 23 with international genomes within a major high-risk lineage ( Figure 6B and Supplementary  24 Results). 25 1 as E. coli ST410 harbouring blaNDM-5 and blaOXA-181 from Egypt 23 , Denmark, and the UK 18 , 2 but, to our knowledge, this is the first report of E. coli carrying both blaNDM-1 and blaOXA-181, 3
which is likely to have disseminated between two sentinel sites (NMC and VSM). We 4 identified five plasmids in the representative strain 14ARS_NMC0074 ( Table 3 , and 5
Supplemental Figure S9 ). The IncX3 plasmid carrying blaOXA-181 (p14ARS_NMC0074-5) 6
was identical to plasmid pAMA1167-OXA-181 isolated previously from an E. coli ST410 7 strain 24 (Supplemental Figure S9 ). Mapping short reads to p14ARS_NMC0074-5 showed 8 that this plasmid is the main vehicle of blaOXA-181 in the Philippines, as in the international 9 genomes ( Figure 6B , 18 ). However, we did not identify any plasmids similar to the IncA/C2 10 plasmid with blaNDM-1 (p14ARS_NMC0074-2), though it shared approximately 90% of its 11 backbone with the IncA/C2 plasmid described above from K. pneumoniae ST147 strain 12 13ARS_VSM0593 (Supplemental Figure S9 ). This plasmid backbone was found in E. coli 13 ST410 genomes from the Philippines, but not in international genomes ( Figure 6B ). Philippines ARSP surveillance data has shown increasing resistance trends for key bug-6 drug combinations ( Figures 1B and 2A ). In this study, the analysis of the dynamics of 7 resistance profiles showed the concomitant expansion of specific resistance phenotypes 8 ( Figure 2B ). By complementing laboratory data with WGS and linking the operational units 9 of laboratory and genomic surveillance, we revealed a diversity of genetic lineages, AMR 10 mechanisms, and vehicles underlying the expansion of carbapenem resistance 11 phenotypes ( Figures 1A and 3 ). The combination of these three components vastly 12 improved our understanding of the routes of dissemination of carbapenem resistance in 13 the Philippines at different geographical scales, from an plasmid-driven local outbreak of 14 K. pneumoniae ST340 (Figure 4 ), to the expansion of a K. pneumoniae ST147 clone 15 carrying NDM-1 in an IncA/C2 plasmid without any close match in international genomes 16 ( Figure 5 ), to the independent introductions of international epidemic clone E. coli ST410 17 that can acquire plasmids of local circulation ( Figure 6 ). 18
A crucial aspect of AMR surveillance is the detection of the emergence and spread of 19 high-risk clones. In traditional laboratory surveillance, resistance profiles can be analysed 20 with spatiotemporal algorithms to detect hospital outbreaks 25 or dissemination of 21 phenotypic subpopulations between hospitals 26 . Cluster detection based on resistance 22 profiles depends on consistent and complete antibiograms within and across sentinel 23 sites. During the course of our project it became apparent that there were inconsistencies 24
in the panels of antibiotics tested by the sentinel sites (missing data or different antibiotics 25 tested), which led to the exclusion of samples from the analysis of the dynamics of 1 resistance profiles ( Figure 2 ). These inconsistencies would also hamper cluster detection 2 based on resistance profiles, or the early detection of novel emerging resistance profiles 3 that could act as indicators of novel high-risk clones. The joint discussions of these 4 observations by the two collaborating teams led to an effort to reinforce the 5 standardization of antibiotic testing across the ARSP sentinel sites, which was coordinated 6 by the ARSRL. At the local scale, we identified a plasmid-driven NICU outbreak of carbapenem-resistant 17 K. pneumoniae. The epidemiological data captured in WHONET was key to support the 18 interpretation of the genomic findings, triggering a retrospective investigation. This 19 previously undetected outbreak was traced to an IncFII plasmid carrying blaNDM-1 in the 20 genetic context of ST340 ( Figure 4A ). Yet, the endemic IncFII plasmid was found across 21 multiple wards, and genetic backgrounds (STs, Figure 4B ). ST340 is a member of the drug-resistant clonal complex 258 and has been reported 2 to cause outbreaks worldwide 28 . Our findings were disseminated to the local stakeholders 3 (i.e., hospital) via a forum with NICU staff, paediatricians and ARSRL representatives. 4
Infection control strategies were implemented, which ultimately bolstered the infection 5 control team of this hospital. Control of healthcare-associated infections is crucial to 6 containing the spread of antimicrobial resistance 29 . The roadmap from sequence data to 7 actionable data for infection control and prevention within a hospital has been mapped by 8 multiple use cases 30, 31 and supported by recent studies on implementation and cost-9 effectiveness in high-resource settings 32, 33 . This study makes a case for extending this 10 roadmap to LMICs that have infection control capacity in place. across five different sites ( Figure 5 ). Clonal expansion followed by geographical 23 dissemination is usually attributed to the acquisition of an AMR determinant 36 . The extent 24 of the geographical dissemination of the different high-risk clones could be attributed to the 25 different plasmid backbones (vehicle), but differences in the genetic background (strain) 1 could also be at play. The presence of a robust AMR surveillance network such as the 2 ARSP is key for the detection of geographical dissemination of high-risk clones at a 3 regional/national level, and for the dissemination of the information to national 4 stakeholders. In this respect, the ARSRL is currently evaluating formats for the inclusion of 5 genomic data into their annual surveillance reports. The reference laboratory directors can 6 also alert hospitals across the country to establish concerted infection control measures, 7
as well as relay this information to the national Department of Health for the formulation of 8 evidence-based guidelines. 9
At the global scale, we identified several high-risk clones of E. coli ST410 circulating the in 10 the Philippines, with evidence of frequent international transmission, in agreement with a 11 previous report 18 Global AMR surveillance networks, such as the WHO GLASS 10 , are paramount to detect 23 the emergence and monitor the spread of resistance at the international level and inform 24 the implementation of targeted prevention and control programmes. The ARSRL has been 25 supplying laboratory surveillance data to GLASS since 2015, and presented their 1 experience with WGS at a WHO technical consultation on the application of WGS for 2 national, regional and global surveillance in 2020, thus becoming an international 3 contributor in both fields. 4
Collecting information on AMR that can be rapidly transformed into action requires 5 harmonized standards, especially at the national and international levels 10 . For laboratory 6
data, WHONET serves this purpose in the ARSP and in over 2,000 clinical, public health, 7 veterinary, and food laboratories in over 120 countries worldwide 26 , while GLASS serves 8 this purpose at the global level. Genomic data are amenable to standardization 29 and the lack of platforms to feedback the actionable genomic data to sentinel sites. In 20 addition, it was expected that the timeline from implementation of a disruptive technology 21 such as WGS to full adoption by all the relevant stakeholders was to exceed the period of 22 one academically-funded project. The continued collaboration with the ARSRL (via an 23 NIHR-funded project) is building on the foundations laid by See and Sequence to tackle 24 some of the challenges mentioned above, and to improve on the translation of genomic 25 data into public-health action and policy. We generated a blueprint for the sustainable 1 implementation of WGS and genomic epidemiology within national surveillance networks 2 in LMICs that can be adapted and utilized within other locations to tackle the global 3 challenge of AMR. missing data for any antibiotic on the panels listed on Table 1 were excluded. included location and date of specimen collection, type of specimen, type of patient (in or 20 outpatient), and sex and age of the patient. We utilized a proxy definition for "infection 21 origin" whereby patient first isolates collected in the community or on either of the first two 22 days of hospitalization were categorized as community infection isolates, while isolates 23 collected on hospital day three or later were categorized as hospital-acquired infection 1 isolates 10 . 2
In this article we focus on carbapenemase-producing organisms. All carbapenemase-3 producing K. pneumoniae and E. coli isolates referred to, confirmed, and banked by the 4 ARSRL in 2013-2014 were selected for the retrospective sequencing survey. 5
Approximately 100 isolates of carbapenemase-producing P. aeruginosa and A. baumannii 6 each, were selected according to the following criteria: i) referred to ARSRL in 2013-2014; 7
ii) complete resistance profile (i.e., no missing data); iii) overall prevalence of the Lyophilisates of the selected bacterial isolates were re-suspended in 0.5 mL of tryptic soy 20 broth, plated onto MacConkey agar plates, and incubated at 35-37°C for 18-24 hours. The 21 species identity of the revived bacterial isolates was confirmed by characterization of the 22 colony morphology and conventional biochemical tests (e.g., oxidase, motility, and sugar 23 fermentation using triple sugar iron agar test). Phenotypic re-testing was performed on the 24 resuscitated isolates based on the phenotype stored in WHONET. Carbapenemase 25 production in resuscitated isolates of Enterobacteriaceae was tested with the modified 1 Hodge test (MHT), and confirmed using the imipenem MIC method with imipenem Etest 2 strips (BioMerieux). P. aeruginosa and A. baumanii were screened for metallo-beta-3 lactamase production using the EDTA synergy test between imipenem disk (10ug) and 4 EDTA (750ug/mL), which was confirmed by imipenem/imipenem inhibitor (IP/IPI) Etest Annotated assemblies were produced using the pipeline described in 51 . For each sample, 1 sequence reads were used to create multiple assemblies using VelvetOptimiser v2.2.5 52 2 and Velvet v1.2 53 . An assembly improvement step was applied to the assembly with the 3 best N50 and contigs were scaffolded using SSPACE 54 and sequence gaps filled using 4 GapFiller 55 . Automated annotation was performed using PROKKA v1.5 56 and a genus 5 specific database from RefSeq 50 . The quality of the assemblies was assessed for total 6 size, number of contigs, N50, and GC content appropriate for each species, with all 7 genomes passing quality control characterized by assemblies of <150 contigs, and N50 > 8 60,000. 9
10

Phylogenetic analysis 11
Evolutionary relationships between isolates were inferred from single nucleotide 12 polymorphisms (SNPs) by mapping the paired-end reads to reference genomes, using the 13 Burrows Wheeler aligner (BWA) v0.7.12 57 to produce a BAM file. PCR duplicate reads 14
were identified using Picard v1.92 58 and flagged as duplicates in the BAM file. 15
Variation detection was performed using samtools mpileup v0.1.19 59 with parameters "-d 16 1000 -DSugBf" and bcftools v0.1.19 60 to produce a BCF file of all variant sites. The option 17
to call genotypes at variant sites was passed to the bcftools call. All bases were filtered to 18 remove those with uncertainty in the base call. The bcftools variant quality score was 19 required to be greater than 50 (quality < 50) and mapping quality greater than 30 20 (map_quality < 30). If not all reads gave the same base call, the allele frequency, as 21 calculated by bcftools, was required to be either 0 for bases called the same as the 22 reference, or 1 for bases called as a SNP (af1 < 0.95). The majority base call was required 23 to be present in at least 75% of reads mapping at the base, (ratio < 0.75), and the 24 minimum mapping depth required was 4 reads, at least two of which had to map to each 1 strand (depth < 4, depth_strand < 2). Finally, strand_bias was required to be less than 2 0.001, map_bias less than 0.001 and tail_bias less than 0.001. If any of these filters were 3 not met, the base was called as uncertain. 4
A pseudo-genome was constructed by substituting the base call at each site (variant and 5 non-variant) in the BCF file into the reference genome and any site called as uncertain 6 was substituted with an N. Insertions with respect to the reference genome were ignored 7 and deletions with respect to the reference genome were filled with N's in the pseudo-8 genome to keep it aligned and the same length as the reference genome used for read 9 mapping. For sequence-type specific phylogenies, mobile genetic elements (MGEs) and 10 recombination regions detected with Gubbins v1.4.10 61 were masked from the alignment 11 of pseudogenomes. Alignments of only variant positions were inferred with snp-sites 12 v2.4.1 62 , and were also used to compute pairwise SNP differences between isolates with 13 an in-house script. 
In silico predictions of AMR determinants and plasmid replicons 21
Known antibiotic resistance determinants were identified using Antibiotic Resistance 22
Identification By Assembly v.2.6.1 (ARIBA 64 ). For acquired genes an in-house curated 23 database comprising 2316 known resistance gene variants was used 24 (https://figshare.com/s/94437a301288969109c2) 65 . Full-length assembled matches with 1 identity >90% and coverage >5x were considered as evidence of the presence of the gene 2 in the query genome. Further manual inspection of the results excluded 13 matches that 3 passed the above filters but that were suspected low-level contamination. Mutations in 4 ompK35 and ompK36 genes were detected with ARIBA and the Comprehensive 5
Antimicrobial Resistance Database (CARD, 44 ) and the output was inspected for 6 truncations, interruptions and frameshifts. 7
Plasmid replicons were identified with ARIBA and the PlasmidFinder database 66 . Full-8 length assembled matches with 100% identity were considered as evidence of the 9 presence of the replicon gene. 10
11
In silico multi-locus sequence typing 12
Multi-locus sequence types (STs) were determined from assemblies with MLSTcheck 13 v1.007001 67 or from sequence reads with ARIBA 64 , using species-specific databases 14 hosted at PubMLST 68 for E. coli 69 , A. baumannii 70 , P. aeruginosa 71 , or at BIGSdb 68 for 15 K. pneumoniae 72 . 16
MLST calls from P. aeruginosa genome sequences were manually curated as we noted 17 the presence of two genes exhibiting 100% sequence identity to different acsA alleles in 18 the pubmlst database (accessed April 2019), which confounded the in silico predictions. 19
This was not privy to the genomes is this study, since the genome sequence of reference 20 strain NCGM2_S1 (accession AP012280), known to belong to ST235, showed two genes 21 with locus tags NCGM2_1665 (nt position 1808730-1810685) and NCGM2_0806 (nt 22 positions c879796-881733) that are annotated as acsA and acsB, respectively, and are 23 100% identical to alleles acsA_38 and acsA_225, respectively 24 (https://pubmlst.org/data/alleles/paeruginosa/acsA.tfa). Furthermore, the same was only 1 observed for the acsA allele both from assemblies (MLST_check) and raw reads (ARIBA-2 MLST), and therefore unlikely the result of contamination with other strains. Allele acsA_38 3 defines ST235, but allele acsA_225 defines a novel ST. Thus, when two different acsA 4 alleles were detected in a P. aeruginosa genome we selected the one associated with a 5 known ST. The presence of AMR genes and plasmid replicons in the plasmid sequences was 18 detected with Resfinder 45 and PlasmidFinder 66 , respectively. Matches with identity larger 19 than 98% were reported. Detailed annotations of plasmids were obtained with MARA 76 . 20
Visual comparisons between plasmid sequences were created with BRIG v1.0 77 with 21 default BLAST parameters. 22
The distribution of plasmids across draft genomes was inferred by mapping short reads to 23 the plasmid sequences with smalt v0.7.4 with identity threshold y=96% and random 24 alignment of reads with multiple mapping positions of equal score (-r 1). The BAM file was 1 sorted and indexed with samtools v0.1.19-44428cd 59 , which was also used to and 2 generate a pileup (mpileup -DSugBf) of the alignment records in BCF format. A pseudo-3 plasmid sequence in fastq format was constructed with the bcftools view and vcfutils.pl 4 vcf2fq programs, and the sequence length coverage (%) of the reference plasmid was 5 computed. 6 identified by mapping the genomes to reference AMA1167, and masking regions 5 corresponding to mobile genetic elements and recombination. The distribution of plasmids 6 with carbapenemases genes in (B) was inferred by mapping the short reads of the 7 genomes to the complete plasmid sequences, and a match was counted when the reads 8 covered at least 95% of the sequence length with at least 5x depth of coverage. The full 9
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data are available at https://microreact.org/project/ARSP_ECO_ST410 (A) and 10 https://microreact.org/project/ARSP_ECO_ST410_GLOBAL (B). 11 12 The replicons and AMR genes were identified with the plasmidFinder and Resfinder 7 databases, respectively. Match Accession indicates the accession number when at least 8 one match of more than 90% query sequence coverage and 99% identity was found in the 9 NCBI nucleotide database. 10 by the different colours. Short reads of the 33 isolates were mapped to the p13ARS_MMH0112-3 and the 10 p14ARS_MMH0055-5 sequences and a plasmid match was counted when the reads covered at least 95% of 11 the sequence length with at least 5x depth of coverage. Maximum-likelihood tree inferred from 809 SNP positions identified by mapping the genomes to reference 7 MS6671 (LN824133.1) and masking regions corresponding to mobile genetic elements and recombination.
8
The distribution of plasmids with carbapenemases genes was inferred by mapping the short reads of the 9 genomes to the complete plasmid sequences, and a match was counted when the reads covered at least 10 95% of the sequence length with at least 5x depth of coverage. The full data are available at 11 https://microreact.org/project/ARSP_KPN_ST147_2013-14. 
9
The distribution of plasmids with carbapenemases genes in (B) was inferred by mapping the short reads of 10 the genomes to the complete plasmid sequences, and a match was counted when the reads covered at least 11 95% of the sequence length with at least 5x depth of coverage. The full data are available at 12 https://microreact.org/project/ARSP_ECO_ST410 (A) and 13 https://microreact.org/project/ARSP_ECO_ST410_GLOBAL (B).
